Efficient Management of First line ALK-rearranged NSCLC - Part VIII

Explore first-line management strategies for ALK-rearranged NSCLC using targeted therapies to improve patient outcomes.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

In this webinar, a detailed discussion is done on understanding the evolutions in treatment and diagnosis of lung cancer.

Speakers : Dr. Lalit Sharma

Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion

Explore the advancements in lung cancer treatment with insights from Dr. Lalit Sharma and Manipal Hospitals.

Speakers : Dr. Lalit Sharma

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Pushpak Chirmade ,Dr Shailesh Bondarde ,Dr Kaushal Patel ,Dr Suhas Aagre ,Dr Sandip Ganguly

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Pushpak Chirmade ,Dr Shailesh Bondarde ,Dr Kaushal Patel ,Dr Suhas Aagre ,Dr Sandip Ganguly

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Pushpak Chirmade ,Dr Shailesh Bondarde ,Dr Kaushal Patel ,Dr Suhas Aagre ,Dr Sandip Ganguly

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Pushpak Chirmade ,Dr Shailesh Bondarde ,Dr Kaushal Patel ,Dr Suhas Aagre ,Dr Sandip Ganguly

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Pushpak Chirmade ,Dr Shailesh Bondarde ,Dr Kaushal Patel ,Dr Suhas Aagre ,Dr Sandip Ganguly

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Pushpak Chirmade ,Dr Shailesh Bondarde ,Dr Kaushal Patel ,Dr Suhas Aagre ,Dr Sandip Ganguly

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

In this webinar, a detailed discussion is done on the understanding of the molecular differences between EGFR AXON 19 Deletion & EXON 21 L858R Mutatio

Speakers : Dr Sandip Ganguly ,Dr Suhas Aagre ,Dr Kaushal Patel ,Dr Shailesh Bondarde ,Dr Pushpak Chirmade


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

FDA approves rivanetin as the first-line treatment for lung cancer.

3.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

4.

New First-Line Option for Advanced ALK-Positive Lung Cancer

5.

Certain surgical gestures during prostate removal linked to better sexual function recovery


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot